This bill expands Medicaid coverage to include medically necessary ovulation enhancing drugs and related medical services for individuals aged 21 to 44 who are experiencing infertility. The covered services consist of office visits, hysterosalpingograms, pelvic ultrasounds, and blood testing, with a limit of three treatment cycles per beneficiary's lifetime. Infertility is defined as the inability to conceive after 12 months of unprotected intercourse for individuals aged 21 to 34, or after six months for those aged 35 to 44. The bill aims to enhance access to reproductive health care for individuals facing challenges with conception.

To implement these changes, the bill amends Section 6 of P.L.1968, c.413 (C.30:4D-6) by adding provisions that specify the age range of beneficiaries and the definition of infertility. It also empowers the Commissioner of Human Services to apply for necessary state plan amendments or waivers to secure federal financial participation for Medicaid expenditures. Furthermore, the Commissioner is required to adopt rules and regulations to facilitate the bill's implementation, which will take effect four months after enactment, although anticipatory administrative actions may be taken beforehand.

Statutes affected:
Introduced: 30:4D-6